Table 1.

Demographics and clinical characteristics of the healthy and patient cohorts

	Normal			CP			PDAC
	Cases (n)	Gender	Age range (median)	Cases (n)	Gender	Age range (median)	Cases (n)	Gender	Age range (median)	Stage/n plasma^a
LON	87	M = 46	28–87	45	M = 32	29–82	60	M = 38	29–82	I = 4/4
		F = 41	(55)		F = 13	(53)		F = 22	(64)	IIA = 1/1
										IIB = 13/13
										III = 33/30
										IV = 6/5
										U = 3/3
Plasma	28	M = 16	28–67	19	M = 14	29–74	56	M = 34	29–82
(CA19.9)		F = 12	(46)		F = 5	(54)		F = 22	(64)
LIV	0	N/A	N/A	41	M = 25	29–82	91	M = 53	39–83	I = 3/3
					F = 16	(51)		F = 38	(68)	IIA = 8/8
										IIB = 42/42
										III = 38/38
										IV = 0/0
										U = 0/0
Plasma	0	N/A	N/A	31	M = 17	37–73	91	M = 53	39–83
(CA19.9)					F = 14	(51)		F = 38	(68)
SPA	0	N/A	N/A	6	M = 4	54–68	41	M = 23	43–94	I = 0/NA
					F = 2	(57)		F = 18	(72)	II = 0/NA
										III = 0/NA
										IV = 0/NA
										U = 41/NA
Plasma (CA19.9)	0	N/A	N/A	0	N/A	N/A	0	N/A	N/A
Total	87	M = 46	28–87	92	M = 61	29–82	192	M = 114	29–94	I = 7/7
		F = 41	(55)		F = 31	(54)		F = 78	(68)	IIA = 9/9
										IIB = 55/55
										III = 71/68
										IV = 6/5
										U = 44/3
Plasma (CA19.9)	28	M = 16	28–67	50	M = 31	29–74	147	M = 87	29–83
		F = 12	(46)		F = 19	(53)		F = 60	(67)

NOTE: Total urine = 371; total plasma = 147.

↵^a Number of cases with plasma CA19.9.